

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.75631555 |
| 2 | fucose catabolic process (GO:0019317) | 4.67475855 |
| 3 | L-fucose metabolic process (GO:0042354) | 4.67475855 |
| 4 | L-fucose catabolic process (GO:0042355) | 4.67475855 |
| 5 | DNA deamination (GO:0045006) | 4.40588280 |
| 6 | protein polyglutamylation (GO:0018095) | 4.18708975 |
| 7 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.91292867 |
| 8 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.65294591 |
| 9 | detection of light stimulus involved in visual perception (GO:0050908) | 3.65294591 |
| 10 | regulation of action potential (GO:0098900) | 3.59733375 |
| 11 | platelet dense granule organization (GO:0060155) | 3.59186601 |
| 12 | kynurenine metabolic process (GO:0070189) | 3.57492283 |
| 13 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.51530330 |
| 14 | tryptophan catabolic process (GO:0006569) | 3.46695244 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 3.46695244 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 3.46695244 |
| 17 | response to pheromone (GO:0019236) | 3.45762642 |
| 18 | negative regulation of mast cell activation (GO:0033004) | 3.36892117 |
| 19 | regulation of memory T cell differentiation (GO:0043380) | 3.36336574 |
| 20 | negative regulation of telomere maintenance (GO:0032205) | 3.34402726 |
| 21 | neuronal action potential propagation (GO:0019227) | 3.34391804 |
| 22 | neuronal action potential (GO:0019228) | 3.29222094 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 3.28727625 |
| 24 | indolalkylamine metabolic process (GO:0006586) | 3.27186213 |
| 25 | regulation of cilium movement (GO:0003352) | 3.27109626 |
| 26 | axoneme assembly (GO:0035082) | 3.23994960 |
| 27 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.20343287 |
| 28 | protein complex biogenesis (GO:0070271) | 3.18698930 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.15005987 |
| 30 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.14682882 |
| 31 | piRNA metabolic process (GO:0034587) | 3.13981708 |
| 32 | positive regulation of action potential (GO:0045760) | 3.13329020 |
| 33 | protein neddylation (GO:0045116) | 3.09702005 |
| 34 | glycerophospholipid catabolic process (GO:0046475) | 3.08973385 |
| 35 | dendritic spine morphogenesis (GO:0060997) | 3.05959598 |
| 36 | ketone body metabolic process (GO:1902224) | 2.98909761 |
| 37 | microtubule severing (GO:0051013) | 2.98011871 |
| 38 | cornea development in camera-type eye (GO:0061303) | 2.96952344 |
| 39 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.96740683 |
| 40 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.96740683 |
| 41 | NADH dehydrogenase complex assembly (GO:0010257) | 2.96740683 |
| 42 | protein-cofactor linkage (GO:0018065) | 2.96024236 |
| 43 | adaptation of signaling pathway (GO:0023058) | 2.94567286 |
| 44 | serotonin metabolic process (GO:0042428) | 2.94350436 |
| 45 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.93970886 |
| 46 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.93729078 |
| 47 | tryptophan metabolic process (GO:0006568) | 2.93274234 |
| 48 | indole-containing compound metabolic process (GO:0042430) | 2.88177042 |
| 49 | synaptic transmission, cholinergic (GO:0007271) | 2.88095905 |
| 50 | primary amino compound metabolic process (GO:1901160) | 2.88038142 |
| 51 | epithelial cilium movement (GO:0003351) | 2.87354050 |
| 52 | kidney morphogenesis (GO:0060993) | 2.87009533 |
| 53 | nonmotile primary cilium assembly (GO:0035058) | 2.85458123 |
| 54 | parturition (GO:0007567) | 2.84460376 |
| 55 | respiratory chain complex IV assembly (GO:0008535) | 2.84033255 |
| 56 | reflex (GO:0060004) | 2.82542328 |
| 57 | somite development (GO:0061053) | 2.80747207 |
| 58 | nephron epithelium morphogenesis (GO:0072088) | 2.80387466 |
| 59 | nephron tubule morphogenesis (GO:0072078) | 2.80387466 |
| 60 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.80327065 |
| 61 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.74991567 |
| 62 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.74991567 |
| 63 | behavioral response to ethanol (GO:0048149) | 2.74051726 |
| 64 | positive regulation of fatty acid transport (GO:2000193) | 2.69986335 |
| 65 | cytochrome complex assembly (GO:0017004) | 2.65562047 |
| 66 | protein localization to cilium (GO:0061512) | 2.65454318 |
| 67 | mannosylation (GO:0097502) | 2.64876952 |
| 68 | regulation of microtubule-based movement (GO:0060632) | 2.64684794 |
| 69 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.62576715 |
| 70 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.58515580 |
| 71 | positive regulation of prostaglandin secretion (GO:0032308) | 2.57963248 |
| 72 | cilium morphogenesis (GO:0060271) | 2.57655765 |
| 73 | startle response (GO:0001964) | 2.57269752 |
| 74 | ATP synthesis coupled proton transport (GO:0015986) | 2.55911138 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.55911138 |
| 76 | ubiquinone biosynthetic process (GO:0006744) | 2.55795523 |
| 77 | sulfation (GO:0051923) | 2.52936969 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 2.51710261 |
| 79 | amine catabolic process (GO:0009310) | 2.51710261 |
| 80 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.49253060 |
| 81 | ubiquinone metabolic process (GO:0006743) | 2.48924440 |
| 82 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.48536207 |
| 83 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.48072205 |
| 84 | neural tube formation (GO:0001841) | 2.46473462 |
| 85 | DNA methylation involved in gamete generation (GO:0043046) | 2.45128601 |
| 86 | photoreceptor cell development (GO:0042461) | 2.44861899 |
| 87 | GPI anchor metabolic process (GO:0006505) | 2.43967484 |
| 88 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.43428785 |
| 89 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.42796121 |
| 90 | multicellular organism reproduction (GO:0032504) | 2.42680270 |
| 91 | regulation of neurotransmitter uptake (GO:0051580) | 2.41775531 |
| 92 | action potential (GO:0001508) | 2.41372705 |
| 93 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.41326953 |
| 94 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.41283437 |
| 95 | cilium organization (GO:0044782) | 2.40014814 |
| 96 | cilium movement (GO:0003341) | 2.39695443 |
| 97 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.38084565 |
| 98 | auditory receptor cell stereocilium organization (GO:0060088) | 2.37942933 |
| 99 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.36984745 |
| 100 | membrane depolarization during action potential (GO:0086010) | 2.35154149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.90743829 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.72331906 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.52899892 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.85583629 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.61925805 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59736144 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.49618984 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.44462968 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.19691159 |
| 10 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.12226014 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10069648 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.08540925 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04244816 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97146781 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95735968 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 1.94441554 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 1.93666048 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88600112 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.84111731 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83741631 |
| 21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70789538 |
| 22 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.70672685 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.70130601 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.69729401 |
| 25 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63791798 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62677391 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60955912 |
| 28 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.57322272 |
| 29 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.57291356 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.52955361 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.52560493 |
| 32 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.51980078 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51567297 |
| 34 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.50829411 |
| 35 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45726220 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43864254 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43462496 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42999983 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.42747738 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40439705 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40018012 |
| 42 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39863692 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38574173 |
| 44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37075658 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35671705 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35671705 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35383050 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34456275 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33128052 |
| 50 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32926433 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31984706 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.31740908 |
| 53 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31248057 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31248057 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30294077 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30294077 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30100083 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28695421 |
| 59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28686113 |
| 60 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.27209865 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24528939 |
| 62 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24076264 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23648237 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.22490273 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20513204 |
| 66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20511157 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18276543 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.17175742 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16465898 |
| 70 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16120632 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16120632 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15994825 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15441756 |
| 74 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15056632 |
| 75 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13081000 |
| 76 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12860700 |
| 77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12279305 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12165783 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11864399 |
| 80 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11614485 |
| 81 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.11028284 |
| 82 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10488349 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09762744 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07123848 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06361520 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04854618 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04833030 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03207390 |
| 89 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.03076433 |
| 90 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01138880 |
| 91 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99024980 |
| 92 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.98457537 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98384353 |
| 94 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97727232 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96756941 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96453347 |
| 97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95343595 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94999839 |
| 99 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93526304 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.93477527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008877_abnormal_DNA_methylation | 2.67698626 |
| 2 | MP0003195_calcinosis | 2.67567946 |
| 3 | MP0001968_abnormal_touch/_nociception | 2.66384052 |
| 4 | MP0002102_abnormal_ear_morphology | 2.61452163 |
| 5 | MP0006292_abnormal_olfactory_placode | 2.41186306 |
| 6 | MP0005551_abnormal_eye_electrophysiolog | 2.30767627 |
| 7 | MP0000569_abnormal_digit_pigmentation | 2.28990863 |
| 8 | MP0003787_abnormal_imprinting | 2.26592532 |
| 9 | MP0002736_abnormal_nociception_after | 2.22111049 |
| 10 | MP0001986_abnormal_taste_sensitivity | 2.15778425 |
| 11 | MP0009745_abnormal_behavioral_response | 2.15072370 |
| 12 | MP0003011_delayed_dark_adaptation | 2.14545365 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.12286161 |
| 14 | MP0009046_muscle_twitch | 2.08732467 |
| 15 | MP0004885_abnormal_endolymph | 2.00012387 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 1.98362774 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.97941112 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.93809271 |
| 19 | MP0005084_abnormal_gallbladder_morpholo | 1.92069532 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.90506263 |
| 21 | MP0008872_abnormal_physiological_respon | 1.89417330 |
| 22 | MP0002272_abnormal_nervous_system | 1.86535309 |
| 23 | MP0004142_abnormal_muscle_tone | 1.85033057 |
| 24 | MP0003880_abnormal_central_pattern | 1.79755818 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.79536227 |
| 26 | MP0004147_increased_porphyrin_level | 1.79334561 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.74417062 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74374283 |
| 29 | MP0005253_abnormal_eye_physiology | 1.68267870 |
| 30 | MP0003136_yellow_coat_color | 1.67942875 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.67264871 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.65537104 |
| 33 | MP0003646_muscle_fatigue | 1.64882297 |
| 34 | MP0004742_abnormal_vestibular_system | 1.62853203 |
| 35 | MP0001486_abnormal_startle_reflex | 1.59861579 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.54973370 |
| 37 | MP0004133_heterotaxia | 1.54326124 |
| 38 | MP0002938_white_spotting | 1.52776706 |
| 39 | MP0001529_abnormal_vocalization | 1.52723835 |
| 40 | MP0001485_abnormal_pinna_reflex | 1.51422330 |
| 41 | MP0002163_abnormal_gland_morphology | 1.46746100 |
| 42 | MP0000427_abnormal_hair_cycle | 1.46343844 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.46255572 |
| 44 | MP0002064_seizures | 1.44074902 |
| 45 | MP0002572_abnormal_emotion/affect_behav | 1.43009434 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.40354236 |
| 47 | MP0003122_maternal_imprinting | 1.39118166 |
| 48 | MP0002733_abnormal_thermal_nociception | 1.35773292 |
| 49 | MP0000631_abnormal_neuroendocrine_gland | 1.35177666 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.35135551 |
| 51 | MP0004043_abnormal_pH_regulation | 1.34330159 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.34042088 |
| 53 | MP0001970_abnormal_pain_threshold | 1.31723945 |
| 54 | MP0001905_abnormal_dopamine_level | 1.27758517 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.22289594 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.21212713 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.21202119 |
| 58 | MP0002928_abnormal_bile_duct | 1.20769615 |
| 59 | MP0001984_abnormal_olfaction | 1.20546169 |
| 60 | MP0004924_abnormal_behavior | 1.18255833 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.18255833 |
| 62 | MP0002063_abnormal_learning/memory/cond | 1.17054255 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.16646581 |
| 64 | MP0002234_abnormal_pharynx_morphology | 1.16279437 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.15203922 |
| 66 | MP0002909_abnormal_adrenal_gland | 1.10919260 |
| 67 | MP0003121_genomic_imprinting | 1.07711620 |
| 68 | MP0005389_reproductive_system_phenotype | 1.05532330 |
| 69 | MP0002822_catalepsy | 1.01386314 |
| 70 | MP0005085_abnormal_gallbladder_physiolo | 1.01162391 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.98462293 |
| 72 | MP0003890_abnormal_embryonic-extraembry | 0.98284755 |
| 73 | MP0002160_abnormal_reproductive_system | 0.98284329 |
| 74 | MP0005195_abnormal_posterior_eye | 0.97375721 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.96985250 |
| 76 | MP0003878_abnormal_ear_physiology | 0.96985250 |
| 77 | MP0003252_abnormal_bile_duct | 0.94696370 |
| 78 | MP0002751_abnormal_autonomic_nervous | 0.93733564 |
| 79 | MP0000026_abnormal_inner_ear | 0.92927009 |
| 80 | MP0000778_abnormal_nervous_system | 0.92685798 |
| 81 | MP0005410_abnormal_fertilization | 0.91457703 |
| 82 | MP0003718_maternal_effect | 0.91153190 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.90971129 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.90074137 |
| 85 | MP0003283_abnormal_digestive_organ | 0.88181731 |
| 86 | MP0008789_abnormal_olfactory_epithelium | 0.87579862 |
| 87 | MP0002184_abnormal_innervation | 0.86093178 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.82632048 |
| 89 | MP0001919_abnormal_reproductive_system | 0.82364639 |
| 90 | MP0005332_abnormal_amino_acid | 0.81999115 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.80915728 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.80196469 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.80171634 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.78518316 |
| 95 | MP0001502_abnormal_circadian_rhythm | 0.78435534 |
| 96 | MP0001324_abnormal_eye_pigmentation | 0.77551704 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.76840364 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.76156145 |
| 99 | MP0001293_anophthalmia | 0.72197500 |
| 100 | MP0000538_abnormal_urinary_bladder | 0.71184141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of midbrain morphology (HP:0002418) | 4.46288447 |
| 2 | Molar tooth sign on MRI (HP:0002419) | 4.46288447 |
| 3 | Pancreatic cysts (HP:0001737) | 4.31163661 |
| 4 | Pancreatic fibrosis (HP:0100732) | 3.86133960 |
| 5 | Nephronophthisis (HP:0000090) | 3.72546169 |
| 6 | True hermaphroditism (HP:0010459) | 3.71796021 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.62339001 |
| 8 | Abnormality of the renal cortex (HP:0011035) | 3.25665412 |
| 9 | Type II lissencephaly (HP:0007260) | 3.19613767 |
| 10 | Abnormality of the renal medulla (HP:0100957) | 3.11680942 |
| 11 | Inability to walk (HP:0002540) | 3.09893524 |
| 12 | Medial flaring of the eyebrow (HP:0010747) | 2.98436829 |
| 13 | Abolished electroretinogram (ERG) (HP:0000550) | 2.79620241 |
| 14 | Pendular nystagmus (HP:0012043) | 2.75574552 |
| 15 | Hyperventilation (HP:0002883) | 2.69123031 |
| 16 | Chronic hepatic failure (HP:0100626) | 2.57967506 |
| 17 | Cystic liver disease (HP:0006706) | 2.55133242 |
| 18 | Congenital, generalized hypertrichosis (HP:0004540) | 2.54575890 |
| 19 | Tubular atrophy (HP:0000092) | 2.52189199 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 2.50228639 |
| 21 | Focal motor seizures (HP:0011153) | 2.50009281 |
| 22 | Abnormal drinking behavior (HP:0030082) | 2.49288950 |
| 23 | Polydipsia (HP:0001959) | 2.49288950 |
| 24 | Renal cortical cysts (HP:0000803) | 2.48261738 |
| 25 | Progressive inability to walk (HP:0002505) | 2.47053979 |
| 26 | Hypothermia (HP:0002045) | 2.36884410 |
| 27 | Attenuation of retinal blood vessels (HP:0007843) | 2.36225951 |
| 28 | Large for gestational age (HP:0001520) | 2.34225124 |
| 29 | Gait imbalance (HP:0002141) | 2.34036799 |
| 30 | Sclerocornea (HP:0000647) | 2.31597969 |
| 31 | Broad-based gait (HP:0002136) | 2.31353006 |
| 32 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30176287 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 2.28417123 |
| 34 | Hemiparesis (HP:0001269) | 2.28141071 |
| 35 | Methylmalonic acidemia (HP:0002912) | 2.26316049 |
| 36 | Genetic anticipation (HP:0003743) | 2.23916451 |
| 37 | Gaze-evoked nystagmus (HP:0000640) | 2.23900475 |
| 38 | Lissencephaly (HP:0001339) | 2.20743432 |
| 39 | Stomach cancer (HP:0012126) | 2.20113106 |
| 40 | Keratoconus (HP:0000563) | 2.19472314 |
| 41 | Increased corneal curvature (HP:0100692) | 2.19472314 |
| 42 | Congenital primary aphakia (HP:0007707) | 2.18934580 |
| 43 | Mitochondrial inheritance (HP:0001427) | 2.18571019 |
| 44 | Abnormality of the pons (HP:0007361) | 2.15663875 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.15142820 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.11055092 |
| 47 | Hyperalaninemia (HP:0003348) | 2.11055092 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.11055092 |
| 49 | Abnormality of the labia minora (HP:0012880) | 2.10573262 |
| 50 | Hypomagnesemia (HP:0002917) | 2.09620218 |
| 51 | Anencephaly (HP:0002323) | 2.08836198 |
| 52 | Cerebellar dysplasia (HP:0007033) | 2.08810254 |
| 53 | Polyuria (HP:0000103) | 2.08373719 |
| 54 | Furrowed tongue (HP:0000221) | 2.08230075 |
| 55 | Optic nerve hypoplasia (HP:0000609) | 2.05395349 |
| 56 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05078006 |
| 57 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.04569494 |
| 58 | Abnormal biliary tract physiology (HP:0012439) | 2.04208301 |
| 59 | Bile duct proliferation (HP:0001408) | 2.04208301 |
| 60 | Febrile seizures (HP:0002373) | 2.04024289 |
| 61 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03498646 |
| 62 | Absent speech (HP:0001344) | 2.03388767 |
| 63 | Increased CSF lactate (HP:0002490) | 2.02953878 |
| 64 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.02512893 |
| 65 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.02512893 |
| 66 | Dialeptic seizures (HP:0011146) | 2.01903529 |
| 67 | Focal seizures (HP:0007359) | 2.01635240 |
| 68 | Postaxial foot polydactyly (HP:0001830) | 2.01553391 |
| 69 | Bilateral microphthalmos (HP:0007633) | 2.01348155 |
| 70 | Acute encephalopathy (HP:0006846) | 2.01181922 |
| 71 | Genital tract atresia (HP:0001827) | 2.00169398 |
| 72 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.99771718 |
| 73 | Progressive macrocephaly (HP:0004481) | 1.99063533 |
| 74 | Hypoplasia of the pons (HP:0012110) | 1.97556351 |
| 75 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.96752309 |
| 76 | Congenital hepatic fibrosis (HP:0002612) | 1.95619709 |
| 77 | Absent/shortened dynein arms (HP:0200106) | 1.95284818 |
| 78 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.95284818 |
| 79 | Thyroid-stimulating hormone excess (HP:0002925) | 1.93487242 |
| 80 | Hepatocellular necrosis (HP:0001404) | 1.91190330 |
| 81 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.90186760 |
| 82 | Concave nail (HP:0001598) | 1.89926387 |
| 83 | Vaginal atresia (HP:0000148) | 1.89417237 |
| 84 | Hepatic necrosis (HP:0002605) | 1.88502899 |
| 85 | Intestinal atresia (HP:0011100) | 1.87802382 |
| 86 | Pachygyria (HP:0001302) | 1.86915555 |
| 87 | Agitation (HP:0000713) | 1.86614412 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.82927103 |
| 89 | Severe muscular hypotonia (HP:0006829) | 1.82623974 |
| 90 | Male pseudohermaphroditism (HP:0000037) | 1.82047781 |
| 91 | Decreased central vision (HP:0007663) | 1.80746043 |
| 92 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.80629047 |
| 93 | Increased serum lactate (HP:0002151) | 1.78122958 |
| 94 | Tachypnea (HP:0002789) | 1.77819462 |
| 95 | Decreased circulating renin level (HP:0003351) | 1.76962422 |
| 96 | Patellar aplasia (HP:0006443) | 1.75978522 |
| 97 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.75060948 |
| 98 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.74887044 |
| 99 | Methylmalonic aciduria (HP:0012120) | 1.73672848 |
| 100 | Optic disc pallor (HP:0000543) | 1.71869080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.65883226 |
| 2 | ADRBK2 | 3.20066930 |
| 3 | WNK3 | 3.18398356 |
| 4 | GRK1 | 2.82678276 |
| 5 | WNK4 | 2.76807114 |
| 6 | MAP4K2 | 2.74233726 |
| 7 | BMPR1B | 2.65408175 |
| 8 | PINK1 | 2.55791150 |
| 9 | ZAK | 2.50940410 |
| 10 | TLK1 | 2.30043694 |
| 11 | NUAK1 | 2.29039123 |
| 12 | TXK | 2.14540928 |
| 13 | TAOK3 | 2.04557540 |
| 14 | CASK | 1.94334126 |
| 15 | MAPK13 | 1.94314486 |
| 16 | OXSR1 | 1.87183408 |
| 17 | STK39 | 1.77510714 |
| 18 | INSRR | 1.66452272 |
| 19 | DYRK2 | 1.57087291 |
| 20 | MARK1 | 1.47756007 |
| 21 | PAK3 | 1.43279289 |
| 22 | TNIK | 1.39495100 |
| 23 | PNCK | 1.36390194 |
| 24 | ACVR1B | 1.31642435 |
| 25 | CDK19 | 1.28602251 |
| 26 | MAP3K4 | 1.27607851 |
| 27 | TIE1 | 1.27090266 |
| 28 | DAPK2 | 1.19662975 |
| 29 | MKNK2 | 1.16864886 |
| 30 | TRIM28 | 1.13374526 |
| 31 | PHKG1 | 1.07292008 |
| 32 | PHKG2 | 1.07292008 |
| 33 | ADRBK1 | 1.06287563 |
| 34 | BCR | 1.05962778 |
| 35 | MAP2K7 | 1.03150403 |
| 36 | TGFBR1 | 1.02151913 |
| 37 | PRKCG | 1.00559942 |
| 38 | PIK3CA | 0.98533568 |
| 39 | BCKDK | 0.96423678 |
| 40 | CAMKK2 | 0.95041194 |
| 41 | CSNK1G2 | 0.93304816 |
| 42 | PRKCE | 0.91415354 |
| 43 | MST4 | 0.89337304 |
| 44 | CSNK1G1 | 0.87483194 |
| 45 | NME1 | 0.85498826 |
| 46 | SIK2 | 0.85360744 |
| 47 | VRK2 | 0.84733753 |
| 48 | MAPKAPK3 | 0.84730137 |
| 49 | MAPK15 | 0.84099079 |
| 50 | STK16 | 0.81671922 |
| 51 | VRK1 | 0.80770950 |
| 52 | CSNK1G3 | 0.79873776 |
| 53 | NTRK3 | 0.77289032 |
| 54 | NTRK2 | 0.74731931 |
| 55 | IKBKB | 0.74397260 |
| 56 | EPHB2 | 0.73633363 |
| 57 | PLK2 | 0.69616235 |
| 58 | PRKCQ | 0.69375472 |
| 59 | MAP2K6 | 0.64065508 |
| 60 | GRK7 | 0.59140832 |
| 61 | CAMK2A | 0.58819451 |
| 62 | PTK2B | 0.57986511 |
| 63 | KIT | 0.57363165 |
| 64 | CAMK1 | 0.57109563 |
| 65 | CSNK1A1L | 0.56799536 |
| 66 | RPS6KA5 | 0.54230855 |
| 67 | TEC | 0.51791889 |
| 68 | PRKACA | 0.51388777 |
| 69 | EIF2AK3 | 0.50612135 |
| 70 | PASK | 0.47392518 |
| 71 | OBSCN | 0.46712678 |
| 72 | PKN1 | 0.44898428 |
| 73 | MKNK1 | 0.44024389 |
| 74 | ERBB3 | 0.43536648 |
| 75 | STK11 | 0.43196111 |
| 76 | CSNK1A1 | 0.43152229 |
| 77 | STK38L | 0.42592687 |
| 78 | PLK3 | 0.42290211 |
| 79 | PRKCI | 0.40021155 |
| 80 | FGFR2 | 0.39974412 |
| 81 | ITK | 0.39104954 |
| 82 | PRKCZ | 0.39019974 |
| 83 | FER | 0.38421901 |
| 84 | EPHA4 | 0.37684503 |
| 85 | CHUK | 0.37217402 |
| 86 | SYK | 0.36936416 |
| 87 | PRKCA | 0.34870113 |
| 88 | EPHA3 | 0.34550302 |
| 89 | GRK5 | 0.33944863 |
| 90 | MUSK | 0.33236088 |
| 91 | CSNK1D | 0.32931279 |
| 92 | MAPKAPK5 | 0.32053428 |
| 93 | MATK | 0.31364248 |
| 94 | CAMK4 | 0.31295812 |
| 95 | PRKG1 | 0.30914123 |
| 96 | CAMK2D | 0.29601905 |
| 97 | NLK | 0.28564407 |
| 98 | STK3 | 0.28360760 |
| 99 | IGF1R | 0.28345498 |
| 100 | MAP2K2 | 0.28186124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.75992274 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.64891601 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.60799084 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.46068115 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.45822499 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.38011745 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.29576866 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21911711 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.19066062 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.11750155 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08962138 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.03552992 |
| 13 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.02807251 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.99512034 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.88430937 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85224956 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.85141808 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.83583685 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.79216286 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63472102 |
| 21 | RNA polymerase_Homo sapiens_hsa03020 | 1.61612015 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57345807 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.50697740 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50581431 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50522914 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50004168 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39821228 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.39551501 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.37037223 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.36151871 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35193444 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.34665046 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.31756042 |
| 34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.30753095 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20847106 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19011281 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14833730 |
| 38 | Alzheimers disease_Homo sapiens_hsa05010 | 1.14127103 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13656003 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11480535 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10825955 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10629748 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.10361964 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09414381 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04778384 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 1.04305543 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98942912 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97641841 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97435521 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 0.96548811 |
| 51 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.96294492 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.95539287 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.91958973 |
| 54 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91834978 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.89762371 |
| 56 | Ribosome_Homo sapiens_hsa03010 | 0.88871120 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87548204 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87498065 |
| 59 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86485020 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.82343608 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80357354 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80209764 |
| 63 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78020504 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76239058 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74648710 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72949903 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71079718 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69253589 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.67373098 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66287401 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65900212 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.65483427 |
| 73 | Mineral absorption_Homo sapiens_hsa04978 | 0.63361642 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63043572 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61483297 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61387815 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60098620 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.57008535 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56576478 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.56523437 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.54255362 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53016124 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51053466 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50316099 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49345376 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48638888 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47297505 |
| 88 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45625036 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44389798 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43376292 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42972472 |
| 92 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41629638 |
| 93 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40875132 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40860582 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40496293 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40326028 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37665080 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35885800 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34429788 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.32081129 |

